144 related articles for article (PubMed ID: 27981553)
1. A circulating serum miRNA panel as early detection biomarkers of cervical intraepithelial neoplasia.
Xin F; Liu P; Ma CF
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4846-4851. PubMed ID: 27981553
[TBL] [Abstract][Full Text] [Related]
2. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.
Zhang Y; Zhang D; Wang F; Xu D; Guo Y; Cui W
Sci Rep; 2015 Dec; 5():17942. PubMed ID: 26656154
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer.
Liu P; Xin F; Ma CF
Genet Mol Res; 2015 Dec; 14(4):17995-8002. PubMed ID: 26782446
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
5. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer.
Kong Q; Tang Z; Xiang F; Jiang J; Yue H; Wu R; Kang X
Clin Lab; 2017 Feb; 63(2):335-340. PubMed ID: 28182350
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm.
Cheung TH; Man KN; Yu MY; Yim SF; Siu NS; Lo KW; Doran G; Wong RR; Wang VW; Smith DI; Worley MJ; Berkowitz RS; Chung TK; Wong YF
Cell Cycle; 2012 Aug; 11(15):2876-84. PubMed ID: 22801550
[TBL] [Abstract][Full Text] [Related]
8. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.
Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM
Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437
[TBL] [Abstract][Full Text] [Related]
9. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors.
Zheng M; Hou L; Ma Y; Zhou L; Wang F; Cheng B; Wang W; Lu B; Liu P; Lu W; Lu Y
Mol Cancer; 2019 Apr; 18(1):76. PubMed ID: 30940131
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.
Liu SS; Chan KKL; Chu DKH; Wei TN; Lau LSK; Ngu SF; Chu MMY; Tse KY; Ip PPC; Ng EKO; Cheung ANY; Ngan HYS
Mol Oncol; 2018 Dec; 12(12):2009-2022. PubMed ID: 30221475
[TBL] [Abstract][Full Text] [Related]
11. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
12. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood circulating microRNA-4636/-143 for the prognosis of cervical cancer.
Yin S; Yang M; Li X; Zhang K; Tian J; Luo C; Bai R; Lu Y; Wang M
J Cell Biochem; 2020 Jan; 121(1):596-608. PubMed ID: 31407404
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated microRNAs involved in the progression of cervical neoplasm.
Zeng K; Zheng W; Mo X; Liu F; Li M; Liu Z; Zhang W; Hu X
Arch Gynecol Obstet; 2015 Oct; 292(4):905-13. PubMed ID: 25851497
[TBL] [Abstract][Full Text] [Related]
15. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
[TBL] [Abstract][Full Text] [Related]
16. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
Zhao S; Yao D; Chen J; Ding N
Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
[TBL] [Abstract][Full Text] [Related]
17. Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
Yang J; Yan Z; Wang Y; Xu J; Li R; Li C; Liu S; Shi L; Yao Y
BMC Cancer; 2021 Sep; 21(1):997. PubMed ID: 34488676
[TBL] [Abstract][Full Text] [Related]
18. Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women.
Sharma S; Hussain S; Soni K; Singhal P; Tripathi R; Ramachandran VG; Sharma S; Das S; Pillai B; Bharadwaj M
Tumour Biol; 2016 Apr; 37(4):4585-95. PubMed ID: 26508022
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis.
Ocadiz-Delgado R; Lizcano-Meneses S; Trejo-Vazquez JA; Conde-Perezprina JC; Garrido-Palmas F; Alvarez-Rios E; García-Villa E; Ruiz G; Illades-Aguiar B; Leyva-Vázquez MA; García-Carrancá A; Gariglio P
APMIS; 2021 Feb; 129(2):70-79. PubMed ID: 33112434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]